课题基金 / 基金详情

Pathophysiological role of mast cells in cardiovascular diseases.

Pathophysiological role of mast cells in cardiovascular diseases.
肥大细胞在心血管疾病中的病理生理作用。
批准号:
16590193
负责人:
SHIOTA Naotaka
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

SHIOTA Naotaka的其他基金

相似基金

相关文献

中文摘要
翻译
肥大细胞是一种多能炎性细胞,表达多种生物活性因子,如细胞因子、生长因子、蛋白酶等。肥大细胞位于心血管组织中。然而,肥大细胞在心血管疾病发病机制中的作用尚不清楚我们目前的研究试图通过分析自发性高血压大鼠(SHR)来阐明肥大细胞的作用,这种大鼠已知会发生遗传性高血压、心脏肥厚和心力衰竭组织化学分析显示,高血压前期(2周龄)SHR大鼠心血管组织肥大细胞数量明显高于正常对照WKY大鼠,肥大细胞是产生tnf - α和乳糜酶的主要细胞之一。此外,SHR大鼠心血管组织中tnf - α、NF-kB、IL-6、SCF和c-kit mRNA水平高于WKY大鼠为了进一步研究肥大细胞在SHR中的作用,我们评估了肥大细胞稳定剂曲尼司特对SHR高血压发展的治疗作用。从2周龄开始,给SHR口服孟鲁司特(300 mg/kg/天)10周曲尼司特治疗可显著抑制高血压的发展,并减少SHR心血管组织中肥大细胞的数量。曲尼司特还能抑制血管周围纤维化和血管增厚总之,我们的研究结果支持心血管组织肥大细胞的激活可能在心血管疾病的发病机制中起关键作用的假设。
英文摘要
1 Mast cells are multi-potent inflammatory cells, which express numerous bioactive factors, such as cytokines, growth factors, and proteases. Mast cells are known to locate in cardiovascular tissues. However, the role of mast cells on the pathogenesis of cardiovascular disease is unknown.2 Our present study attempted to clarify the role of mast cells by analyzing spontaneously hypertensive rats (SHR), which is known to develop genetically hypertension, cardiac hypertrophy, and heart failure.3 Histochemical analysis revealed that the number of mast cells in the cardiovascular tissues of prehypertensive (2 weeks-old) SHR was significantly higher than that of normal control WKY rats, and mast cells are one of the major cells producing TNF-alpha and chymase. Furthermore, TNF-alpha,NF-kB,IL-6,SCF and c-kit mRNA levels in the cardiovascular tissues in SHR were higher than those in WKY rats.4 To further investigate the role of mast cells in SHR, we evaluated the therapeutic effects of a mast cell stabilizer, tranilast, on the development of hypertension in SHR. Montelukast (300 mg/kg/day) was orally administered to SHR for 10 weeks, starting at the age of 2 weeks.5 Treatment with tranilast significantly inhibit the development of hypertension, and decreased the number of mast cells in cardiovascular tissues in SHR. Tranilast also suppressed the perivascular fibrosis and vascular thickening.6 In conclusion, our results support the hypothesis that activation of mast cells in cardiovascular tissues may play a key role in the pathogenesis of cardiovascular diseases.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/sj.bjp.0706209
发表时间: 2005-06-01
期刊: BRITISH JOURNAL OF PHARMACOLOGY
影响因子: 7.3
作者: [Shiota, N, Kakizoe, E, Okunishi, H]
通讯作者: Okunishi, H
Pathophysiological role of mast cells on the bone homeostasis.
  • 批准号:
    23590302
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.0万
  • 财政年份:
    2011
  • 负责人:
    SHIOTA Naotaka
  • 依托单位:
国内基金
海外基金
肥大细胞通过Chymase介导β细胞高尔基体应激促进SAP后糖尿病发生的机制研究
  • 批准号:
    2025JJ60668
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    崔贝贝
  • 依托单位:
基于Chymase介导非ACE依赖的AngII生成途径探研冠心V号干预心室重构机制
  • 批准号:
    81774229
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2017
  • 负责人:
    顾宁
  • 依托单位:
基于chymase/AngⅡ途径探讨解毒通络法对大鼠心肌纤维化的影响
  • 批准号:
    81503544
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2015
  • 负责人:
    郭家娟
  • 依托单位:
肥大细胞蛋白酶chymase在大疱性类天疱疮中的免疫病理机制研究
  • 批准号:
    81301370
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    林澜
  • 依托单位: